Recce announced that it signed a second Cooperative Research and Development Agreement (CRADA) with the US Army. This new arrangement with the US Army Institute of Surgical Research (USAISR) will study whether RECCE 327 Gel (R327G) will reduce the bioburden of Methicillin-resistant Staphylococcus a
